Ligand Pharmaceuticals (LGND) Equity Income (2015 - 2020)
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Equity Income (2015 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Ligand Pharmaceuticals | 5.77 Bn | 4.41 Bn | 60.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -25.46 Mn |
| Dec 31, 2019 | 8.48 Mn |
| Sep 30, 2019 | -10.52 Mn |
| Jun 30, 2019 | -12.37 Mn |
| Mar 31, 2019 | 17.29 Mn |
| Dec 31, 2018 | -74.02 Mn |
| Sep 30, 2018 | 59.87 Mn |
| Jun 30, 2018 | 39.88 Mn |
| Mar 31, 2018 | 21.93 Mn |
| Dec 31, 2017 | 4.46 Mn |
| Sep 30, 2017 | -1.02 Mn |
| Jun 30, 2017 | -1.25 Mn |
| Mar 31, 2017 | -1.08 Mn |
| Dec 31, 2016 | -8.99 Mn |
| Sep 30, 2016 | -1.40 Mn |
| Jun 30, 2016 | -11.14 Mn |
| Mar 31, 2016 | -1.61 Mn |
| Dec 31, 2015 | -2.10 Mn |
| Sep 30, 2015 | -2.17 Mn |
| Jun 30, 2015 | -870,000.00 |